
|Articles|December 13, 2004
Medicare drug benefit seen as mixed blessing
The Medicare Modernization Act (MMA) that established the system's first outpatient drug benefit gives pharmacists more questions than answers. The reason is clear: politics. "The entire process is driven by politics," said Dan Mendelson, president of the Health Strategies Consultancy, a Washington, D.C., health policy firm. "Medicare is a political act, and the changes you will see to it will be politically driven."
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Pharmacies Should Be Proactive in Expanding Clinical Services, Reimbursement Pathways | NCPA 2025
4
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
5


























































































































































